Evidence map›Paper›PMID 32745301›Full record

ArticleDevelopmental dynamics : an official publication of the American Association of Anatomists2020

CreLite: An optogenetically controlled Cre/loxP system using red light.

Shuo-Ting Yen, Kenneth A Trimmer, Nader Aboul-Fettouh, Rachel D Mullen, James C Culver, Mary E Dickinson, Richard R Behringer, George T Eisenhoffer

Open access · greenAbstract read
In one paragraph

Article in Developmental dynamics : an official publication of the American Association of Anatomists, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Rebuilding limbs, one cell at a time.Developmental dynamics : an official publication of the American Association of Anatomists · 2022
    Article
  7. Review
  8. Article
  9. Red Light Optogenetics in Neuroscience.Frontiers in cellular neuroscience · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shuo-Ting YenDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Kenneth A TrimmerDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Nader Aboul-FettouhDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Rachel D MullenDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
James C CulverDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas, USA.
Mary E DickinsonDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas, USA.
Richard R BehringerDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
George T EisenhofferDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0003-0188-6782
The University of Texas MD Anderson Cancer Center · USBaylor College of Medicine · US

Funding

Molecular Physiology of the Cardiovascular SystemT32HL007676 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI HAMILTON, SUSAN L · 1989 to 2020
$7.9M
Female Reproductive Tract Development in the MouseR37HD030284 · NICHD · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BEHRINGER, RICHARD R · 2014 to 2023
$4.2M
Regulation of Cell Turnover During Epithelial Tissue HomeostasisR01GM124043 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI EISENHOFFER, GEORGE THOMAS · 2018 to 2022
$2.0M
Light-inducible Cre Transgenic Mouse ModelsR21OD019764 · OD · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BEHRINGER, RICHARD R · 2014 to 2015
$434k
Ben F. Love EndowmentCancer Prevention and Research Institute of Texas RR140077Mark and Linda Quick Basic Science AwardNHLBI NIH HHS T32 HL007676NICHD NIH HHS R37 HD030284NIGMS NIH HHS R01 GM124043NIH HHS R21 OD019764NIH Office of the Director OD19764
6 · The paper itself

Abstract

backgroundPrecise manipulation of gene expression with temporal and spatial control is essential for functional analysis and determining cell lineage relationships in complex biological systems. The cyclic recombinase (Cre)-loxP system is commonly used for gene manipulation at desired times and places. However, specificity is dependent on the availability of tissue- or cell-specific regulatory elements used in combination with Cre. Here, we present CreLite, an optogenetically controlled Cre system using red light in developing zebrafish embryos.

resultsCre activity is disabled by splitting Cre and fusing with the Arabidopsis thaliana red light-inducible binding partners, PhyB and PIF6. Upon red light illumination, the PhyB-CreC and PIF6-CreN fusion proteins come together in the presence of the cofactor phycocyanobilin (PCB) to restore Cre activity. Red light exposure of zebrafish embryos harboring a Cre-dependent multicolor fluorescent protein reporter injected with CreLite mRNAs and PCB resulted in Cre activity as measured by the generation of multispectral cell labeling in several different tissues.

conclusionsOur data show that CreLite can be used for gene manipulations in whole embryos or small groups of cells at different developmental stages, and suggests CreLite may also be useful for temporal and spatial control of gene expression in cell culture, ex vivo organ culture, and other animal models.

Indexed as

ArabidopsisIntegrasesOptogeneticsPlants, Genetically ModifiedCre recombinaseIntegrasesCre/loxPgene expressionoptogeneticszebrafish

Identifiers

PMID32745301
PMCPMC7931845
OpenAlexW3046854059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.